Risks of Kidney Failure Associated With Consumption of Herbal Products Containing Mu Tong or Fangchi: A Population-Based Case-Control Study

被引:72
作者
Lai, Ming-Nan [1 ]
Lai, Jung-Nien [2 ]
Chen, Pau-Chung [1 ]
Hsieh, Shu-Ching [3 ]
Hu, Fu-Chang [4 ]
Wang, Jung-Der [1 ,5 ,6 ]
机构
[1] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 100, Taiwan
[2] Taipei City Hosp, Div Gynaecol Tradit Chinese Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Div Hlth Technol Assessment, Ctr Drug Evaluat, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei 100, Taiwan
关键词
Aristolochic acid; Chinese herb nephropathy; end-stage renal disease; Mu Tong; Fangchi; INTERSTITIAL RENAL FIBROSIS; ARISTOLOCHIC ACID; CHINESE; NEPHROPATHY; DISEASE; TAIWAN; IDENTIFICATION; ANALGESICS; PREVALENCE; IMPACT;
D O I
10.1053/j.ajkd.2009.10.055
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Taiwan has a remarkably high incidence of end-stage renal disease (ESRD). The objective of this study is to determine the association between prescribed herbal products containing aristolochic acid and ESRD. Study Design: Population-based case-control study. Setting & Participants: All new ESRD cases in Taiwan and a simple random sample (200,000 people) drawn from the national health insurance reimbursement database in 1997-2002. Predictor: Age; sex; hypertension; diabetes; cumulative doses of nonsteroidal anti-inflammatory drugs, acetaminophen, and adulterated herbal supplements potentially containing aristolochic acid before the development of chronic kidney disease; and indications for prescribing such herbs, including chronic hepatitis, chronic urinary tract infection, chronic neuralgia, or chronic musculoskeletal diseases. Outcomes & Measurements: Occurrence of ESRD through construction of multiple logistic regression models. Results: There were 36,620 new ESRD cases from 1998 through 2002. After exclusion of cases with chronic kidney disease diagnosed before July 1, 1997, there were 25,843 new cases of ESRD and 184,851 controls in the final analysis. Women, older age, hypertension, and diabetes were significantly associated with increased risks of the development of ESRD. After adjustment for known risk factors, cumulative doses >60 g of Mu Tong (OR, 1.47 [95% CI, 1.01-2.14] for 61-100 g; OR, 5.82 [95% CI, 3.89-8.71] for >200 g) or Fangchi (OR, 1.60 [95% CI, 1.20-2.14] for 61-100 g; OR, 1.94 [95% CI, 1.29-2.92] for >200 g) were associated with increased risk of the development of ESRD with a dose-response relationship. This relationship persisted when analyses were limited to participants who consumed <500 pills of nonsteroidal anti-inflammatory drugs and those without diabetes. Limitations: No measurement of renal function, no contact with patients, over-the-counter sales were not recorded, and potential underestimation of exposure dose for cases and ORs. Conclusions: Consumption of >60 g of Mu Tong or Fangchi from herbal supplements was associated with an increased risk of developing kidney failure. Am J Kidney Dis 55: 507-518. (C) 2010 by the National Kidney Foundation, Inc.
引用
收藏
页码:507 / 518
页数:12
相关论文
共 36 条
[1]  
[Anonymous], 2000, GPE Discussion Paper Series
[2]   Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications [J].
Chang, CH ;
Wang, YM ;
Yang, AH ;
Chiang, SS .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (06) :441-448
[3]  
Chen X., 1994, J JIANGXI U TRADIT C, V15, P10
[4]  
Chuang MS, 2002, ANN REPORT INVESTIGA, V20, P104
[5]  
COLLINS AJ, 2005, AM J KIDNEY DIS, V45, pS217
[6]   Aristolochic acid nephropathy: A worldwide problem [J].
Debelle, Frederic D. ;
Vanherweghem, Jean-Louis ;
Nortier, Joelle L. .
KIDNEY INTERNATIONAL, 2008, 74 (02) :158-169
[7]  
DENG JS, 2002, THESIS CHINA MED U T, P75
[8]  
*DEP HLTH COMM CHI, REG DRUGS
[9]  
*DEP HLTH COMM CHI, UN FORM
[10]  
*DEP HLTH TAIW BUR, C2003 AD ELD HLTH DI